Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment
Source: Streetwise Reports (08/11/2025)
Clinical-stage life sciences company Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) announces topline results from its Phase II clinical study involving patients with acute myocarditis. Read why analysts like this pharmaceutical stock.
read more >
Biotech Announces Topline Results From Cardiovascular Drug Trial
Source: Brandon Folkes (08/11/2025)
Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) Analyst Brandon Folkes reviews Cardiol Therapeutics Inc. after it announced the topline results from its Phase II ARCHER trial of CardiolRx in acute myocarditis.
read more >
Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada
Source: Jason Wittes (08/11/2025)
Top-line results from Cardiol Therapeutics' (CRDL:TSX; CRDL:NASDAQ) ARCHER study for Acute Myocarditis are quite promising, writes Roth Capital Partners Analyst Jason Wittes in an updated research note.
read more >
Canadian Pharma Finds Promising Cardiovascular Breakthrough
Source: Douglas Loe (08/08/2025)
Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) reports headline Phase II data from its 109-patient acute myocarditis study, known as the ARCHER trial. Read to see how one analyst rates the stock.
read more >
Clean Tech Firm Making Important PFAS Breakthrough
Source: Streetwise Reports (07/29/2025)
Clean technology company BioLargo Inc. (BLGO:OTCQX) president and chief executive office shares a mid-year update on the company's achievements so far this year, along with insights into its future prospects through a letter to shareholders.
read more >